silver acetate has been researched along with n-vinyl-2-pyrrolidinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, A; Frandsen, HL; Gao, X; Hadrup, N; Lam, HR; Larsen, EH; Loeschner, K; Mortensen, A; Vogel, U; Wilcks, A | 1 |
| Argentiere, S; Aureli, F; Bianchessi, S; Cella, C; Cubadda, F; D'Amato, M; De Maglie, M; Lenardi, C; Mattiello, S; Milani, P; Raggi, A; Recordati, C; Scanziani, E | 1 |
2 other study(ies) available for silver acetate and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats.
Topics: Acetates; Administration, Oral; Animals; Clinical Chemistry Tests; Dose-Response Relationship, Drug; Female; Hematologic Tests; Ions; Male; Metal Nanoparticles; Nanocomposites; No-Observed-Adverse-Effect Level; Particle Size; Povidone; Rats; Rats, Wistar; Silver Compounds; Specific Pathogen-Free Organisms; Toxicity Tests | 2012 |
Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects.
Topics: Acetates; Animals; Brain; Chemical and Drug Induced Liver Injury; Citric Acid; Gallbladder Diseases; Hemorrhage; Injections, Intravenous; Kidney; Liver; Lung; Male; Mice, Inbred ICR; Nanoparticles; Necrosis; Particle Size; Povidone; Risk Assessment; Silver; Silver Compounds; Spleen; Tissue Distribution | 2016 |